开云app官网登录入口网页版-官方正版

#食管腺#

40篇内容 | 1114人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1821027, encodeId=f6be182102eb9, content=<a href='/topic/show?id=3488101119e7' target=_blank style='color:#2F92EE;'>#食管腺#</a>, objectTitle=北京友谊医院揭示：慢性胃食管反流病诱发食管腺癌的新机制, objectType=article, longId=731563, objectId=064ee31563bc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=064ee31563bc, replyNumber=0, likeNumber=79, createdTime=2022-08-20, rootId=0, userName=yuhaisheng_ibp_32061711, userId=bb182500058, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=064ee31563bc, moduleTitle=北京友谊医院揭示：慢性胃食管反流病诱发食管腺癌的新机制, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=064ee31563bc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1821026, encodeId=cbb81821026e4, content=<a href='/topic/show?id=3488101119e7' target=_blank style='color:#2F92EE;'>#食管腺#</a>, objectTitle=JAMA Oncol：伊匹单抗 vs FOLFOX联合纳武单抗和曲妥珠单抗治疗ERBB2阳性胃食管腺癌, objectType=article, longId=730595, objectId=f470e305957c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f470e305957c, replyNumber=0, likeNumber=97, createdTime=2023-05-05, rootId=0, userName=yuhaisheng_ibp_32061711, userId=bb182500058, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f470e305957c, moduleTitle=JAMA Oncol：伊匹单抗 vs FOLFOX联合纳武单抗和曲妥珠单抗治疗ERBB2阳性胃食管腺癌, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=f470e305957c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1821024, encodeId=f1fb182102426, content=<a href='/topic/show?id=3488101119e7' target=_blank style='color:#2F92EE;'>#食管腺#</a>, objectTitle=J Clin Oncol：PD-L1低表达的晚期胃或食管腺癌(GEAC)患者免疫检查点抑制剂（ICI）的疗效, objectType=article, longId=221539, objectId=ea642215396a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ea642215396a, replyNumber=0, likeNumber=65, createdTime=2022-07-06, rootId=0, userName=yuhaisheng_ibp_32061711, userId=bb182500058, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ea642215396a, moduleTitle=J Clin Oncol：PD-L1低表达的晚期胃或食管腺癌(GEAC)患者免疫检查点抑制剂（ICI）的疗效, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=ea642215396a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1821023, encodeId=239d1821023b2, content=<a href='/topic/show?id=3488101119e7' target=_blank style='color:#2F92EE;'>#食管腺#</a>, objectTitle=Br J Cancer：人群队列研究揭示更年期激素治疗可降低食管腺癌患病风险, objectType=article, longId=219398, objectId=db08219398f4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=db08219398f4, replyNumber=0, likeNumber=90, createdTime=2022-03-26, rootId=0, userName=yuhaisheng_ibp_32061711, userId=bb182500058, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=db08219398f4, moduleTitle=Br J Cancer：人群队列研究揭示更年期激素治疗可降低食管腺癌患病风险, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=db08219398f4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1821019, encodeId=71c918210190d, content=<a href='/topic/show?id=3488101119e7' target=_blank style='color:#2F92EE;'>#食管腺#</a>, objectTitle=AJG：人体中性激素的异常与胃癌和结肠直肠癌有关，而与食管腺癌无关, objectType=article, longId=208484, objectId=c888208484d5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c888208484d5, replyNumber=0, likeNumber=129, createdTime=2021-11-29, rootId=0, userName=yuhaisheng_ibp_32061711, userId=bb182500058, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c888208484d5, moduleTitle=AJG：人体中性激素的异常与胃癌和结肠直肠癌有关，而与食管腺癌无关, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=c888208484d5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1821021, encodeId=d4ea1821021a8, content=<a href='/topic/show?id=3488101119e7' target=_blank style='color:#2F92EE;'>#食管腺#</a>, objectTitle=Lancet：纳武单抗+化疗用于晚期胃食管腺癌的疗效显著优于单纯化疗, objectType=article, longId=212478, objectId=90e32124e8db, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=90e32124e8db, replyNumber=0, likeNumber=71, createdTime=2021-07-22, rootId=0, userName=yuhaisheng_ibp_32061711, userId=bb182500058, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=90e32124e8db, moduleTitle=Lancet：纳武单抗+化疗用于晚期胃食管腺癌的疗效显著优于单纯化疗, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=90e32124e8db)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1821025, encodeId=582a1821025c6, content=<a href='/topic/show?id=3488101119e7' target=_blank style='color:#2F92EE;'>#食管腺#</a>, objectTitle=治疗胃食管腺癌达到90.9%疾病控制率，Zymeworks HER2靶向双特异性抗体显“奇效”, objectType=article, longId=259632, objectId=614325963215, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=614325963215, replyNumber=0, likeNumber=154, createdTime=2022-07-29, rootId=0, userName=yuhaisheng_ibp_32061711, userId=bb182500058, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=614325963215, moduleTitle=治疗胃食管腺癌达到90.9%疾病控制率，Zymeworks HER2靶向双特异性抗体显“奇效”, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=614325963215)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1821022, encodeId=6c851821022ec, content=<a href='/topic/show?id=3488101119e7' target=_blank style='color:#2F92EE;'>#食管腺#</a>, objectTitle=Eur J Cancer：奥沙利铂/卡培他滨联合放疗（OxCapRT）对比紫杉醇/卡铂联合放疗（CarPacRT）新辅助治疗对可切除食管腺癌的疗效和安全性：NeoSCOPE长期随访结果, objectType=article, longId=213266, objectId=96fd2132664f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=96fd2132664f, replyNumber=0, likeNumber=82, createdTime=2022-01-25, rootId=0, userName=yuhaisheng_ibp_32061711, userId=bb182500058, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=96fd2132664f, moduleTitle=Eur J Cancer：奥沙利铂/卡培他滨联合放疗（OxCapRT）对比紫杉醇/卡铂联合放疗（CarPacRT）新辅助治疗对可切除食管腺癌的疗效和安全性：NeoSCOPE长期随访结果, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=96fd2132664f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1821018, encodeId=6a07182101801, content=<a href='/topic/show?id=3488101119e7' target=_blank style='color:#2F92EE;'>#食管腺#</a>, objectTitle=ASCO GI 2020：Zanidatamab在经过治疗的HER2+胃食管腺癌患者中显示出持久的抗肿瘤活性, objectType=article, longId=205972, objectId=009f2059e2f7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=009f2059e2f7, replyNumber=0, likeNumber=90, createdTime=2021-10-12, rootId=0, userName=yuhaisheng_ibp_32061711, userId=bb182500058, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=009f2059e2f7, moduleTitle=ASCO GI 2020：Zanidatamab在经过治疗的HER2+胃食管腺癌患者中显示出持久的抗肿瘤活性, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=009f2059e2f7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1821020, encodeId=1b7218210207b, content=<a href='/topic/show?id=3488101119e7' target=_blank style='color:#2F92EE;'>#食管腺#</a>, objectTitle=Br J Cancer：Mandard分级高：不代表食管腺癌对化疗无反应, objectType=article, longId=208932, objectId=7fa520893267, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7fa520893267, replyNumber=0, likeNumber=83, createdTime=2021-06-01, rootId=0, userName=yuhaisheng_ibp_32061711, userId=bb182500058, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7fa520893267, moduleTitle=Br J Cancer：Mandard分级高：不代表食管腺癌对化疗无反应, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=7fa520893267)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1821016, encodeId=2dc51821016db, content=<a href='/topic/show?id=3488101119e7' target=_blank style='color:#2F92EE;'>#食管腺#</a>, objectTitle=Lancet oncol：Margetuximab联合派姆单抗治疗HER2+的胃食管腺癌, objectType=article, longId=197540, objectId=9b6419e540b8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9b6419e540b8, replyNumber=0, likeNumber=81, createdTime=2020-10-31, rootId=0, userName=yuhaisheng_ibp_32061711, userId=bb182500058, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9b6419e540b8, moduleTitle=Lancet oncol：Margetuximab联合派姆单抗治疗HER2+的胃食管腺癌, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=9b6419e540b8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1821017, encodeId=cce1182101e37, content=<a href='/topic/show?id=3488101119e7' target=_blank style='color:#2F92EE;'>#食管腺#</a>, objectTitle=Clin Gastroenterology H: 性激素水平与食管腺癌和巴雷特食管风险之间的关系, objectType=article, longId=203046, objectId=a13420304628, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a13420304628, replyNumber=0, likeNumber=63, createdTime=2021-03-26, rootId=0, userName=yuhaisheng_ibp_32061711, userId=bb182500058, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a13420304628, moduleTitle=Clin Gastroenterology H: 性激素水平与食管腺癌和巴雷特食管风险之间的关系, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=a13420304628)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1821014, encodeId=6cd41821014ae, content=<a href='/topic/show?id=3488101119e7' target=_blank style='color:#2F92EE;'>#食管腺#</a>, objectTitle=AJG：男性循环性激素水平和食管腺癌风险, objectType=article, longId=186864, objectId=2adb186864ff, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2adb186864ff, replyNumber=0, likeNumber=67, createdTime=2020-07-05, rootId=0, userName=yuhaisheng_ibp_32061711, userId=bb182500058, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2adb186864ff, moduleTitle=AJG：男性循环性激素水平和食管腺癌风险, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=2adb186864ff)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1821015, encodeId=4a4b1821015d7, content=<a href='/topic/show?id=3488101119e7' target=_blank style='color:#2F92EE;'>#食管腺#</a>, objectTitle=Journal of Clinical Oncology：Bemarituzumab治疗晚期胃食管腺癌的I期研究, objectType=article, longId=190022, objectId=7727190022fc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7727190022fc, replyNumber=0, likeNumber=115, createdTime=2020-09-04, rootId=0, userName=yuhaisheng_ibp_32061711, userId=bb182500058, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7727190022fc, moduleTitle=Journal of Clinical Oncology：Bemarituzumab治疗晚期胃食管腺癌的I期研究, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=7727190022fc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1821013, encodeId=deb61821013b5, content=<a href='/topic/show?id=3488101119e7' target=_blank style='color:#2F92EE;'>#食管腺#</a>, objectTitle=Clin Gastroenterology H：患有食管腺癌的年轻人晚期肿瘤发生风险更高并且存活时间更短, objectType=article, longId=176789, objectId=5a771e678937, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5a771e678937, replyNumber=0, likeNumber=81, createdTime=2019-10-27, rootId=0, userName=yuhaisheng_ibp_32061711, userId=bb182500058, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5a771e678937, moduleTitle=Clin Gastroenterology H：患有食管腺癌的年轻人晚期肿瘤发生风险更高并且存活时间更短, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=5a771e678937)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1821012, encodeId=2d7f1821012a4, content=<a href='/topic/show?id=3488101119e7' target=_blank style='color:#2F92EE;'>#食管腺#</a>, objectTitle=CLIN CANCER RES：胃食管腺癌患者循环肿瘤DNA与临床结局之间的关系, objectType=article, longId=156407, objectId=993a15640e74, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=993a15640e74, replyNumber=0, likeNumber=77, createdTime=2019-06-01, rootId=0, userName=yuhaisheng_ibp_32061711, userId=bb182500058, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=993a15640e74, moduleTitle=CLIN CANCER RES：胃食管腺癌患者循环肿瘤DNA与临床结局之间的关系, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=993a15640e74)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1821008, encodeId=546f182100892, content=<a href='/topic/show?id=3488101119e7' target=_blank style='color:#2F92EE;'>#食管腺#</a>, objectTitle=Gastroenterology：不同食管腺癌表型患者的预后差异, objectType=article, longId=147661, objectId=45de14e661f9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=45de14e661f9, replyNumber=0, likeNumber=102, createdTime=2019-03-23, rootId=0, userName=yuhaisheng_ibp_32061711, userId=bb182500058, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=45de14e661f9, moduleTitle=Gastroenterology：不同食管腺癌表型患者的预后差异, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=45de14e661f9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1821010, encodeId=4bcb18210107c, content=<a href='/topic/show?id=3488101119e7' target=_blank style='color:#2F92EE;'>#食管腺#</a>, objectTitle=JAMA Surg：胃和胃食管腺癌根治性切除术术中会诊假阴性率及影响因素, objectType=article, longId=152352, objectId=680315235273, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=680315235273, replyNumber=0, likeNumber=62, createdTime=2018-12-28, rootId=0, userName=yuhaisheng_ibp_32061711, userId=bb182500058, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=680315235273, moduleTitle=JAMA Surg：胃和胃食管腺癌根治性切除术术中会诊假阴性率及影响因素, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=680315235273)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1821009, encodeId=3d9f1821009ef, content=<a href='/topic/show?id=3488101119e7' target=_blank style='color:#2F92EE;'>#食管腺#</a>, objectTitle=Clinical Gastroenterology H：遗传变异与环境因素之间的相互作用影响食管腺癌和Barrett食管的风险, objectType=article, longId=149413, objectId=043c149413cd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=043c149413cd, replyNumber=0, likeNumber=62, createdTime=2018-11-07, rootId=0, userName=yuhaisheng_ibp_32061711, userId=bb182500058, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=043c149413cd, moduleTitle=Clinical Gastroenterology H：遗传变异与环境因素之间的相互作用影响食管腺癌和Barrett食管的风险, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=043c149413cd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1821011, encodeId=6bec182101130, content=<a href='/topic/show?id=3488101119e7' target=_blank style='color:#2F92EE;'>#食管腺#</a>, objectTitle=DDS： Barrett食管的早期诊断能改善食管腺癌的生存率, objectType=article, longId=153962, objectId=77e215396219, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=77e215396219, replyNumber=0, likeNumber=71, createdTime=2018-12-08, rootId=0, userName=yuhaisheng_ibp_32061711, userId=bb182500058, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=77e215396219, moduleTitle=DDS： Barrett食管的早期诊断能改善食管腺癌的生存率, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=77e215396219)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 风湿免疫小助手

食管腺

2020-05-29

yuhaisheng_ibp_32061711 (审核中...)

前往app查看评论内容

#食管腺#

北京友谊医院揭示：慢性胃食管反流病诱发食管腺癌的新机制

2022-08-20

yuhaisheng_ibp_32061711 (审核中...)

前往app查看评论内容

#食管腺#

JAMA Oncol：伊匹单抗 vs FOLFOX联合纳武单抗和曲妥珠单抗治疗ERBB2阳性胃食管腺癌

2023-05-05

yuhaisheng_ibp_32061711 (审核中...)

前往app查看评论内容

#食管腺#

J Clin Oncol：PD-L1低表达的晚期胃或食管腺癌(GEAC)患者免疫检查点抑制剂（ICI）的疗效

2022-07-06

yuhaisheng_ibp_32061711 (审核中...)

前往app查看评论内容

#食管腺#

Br J Cancer：人群队列研究揭示更年期激素治疗可降低食管腺癌患病风险

2022-03-26

yuhaisheng_ibp_32061711 (审核中...)

前往app查看评论内容

#食管腺#

AJG：人体中性激素的异常与胃癌和结肠直肠癌有关，而与食管腺癌无关

2021-11-29

yuhaisheng_ibp_32061711 (审核中...)

前往app查看评论内容

#食管腺#

Lancet：纳武单抗+化疗用于晚期胃食管腺癌的疗效显著优于单纯化疗

2021-07-22

yuhaisheng_ibp_32061711 (审核中...)

前往app查看评论内容

#食管腺#

治疗胃食管腺癌达到90.9%疾病控制率，Zymeworks HER2靶向双特异性抗体显“奇效”

2022-07-29

yuhaisheng_ibp_32061711 (审核中...)

前往app查看评论内容

#食管腺#

Eur J Cancer：奥沙利铂/卡培他滨联合放疗（OxCapRT）对比紫杉醇/卡铂联合放疗（CarPacRT）新辅助治疗对可切除食管腺癌的疗效和安全性：NeoSCOPE长期随访结果

2022-01-25

yuhaisheng_ibp_32061711 (审核中...)

前往app查看评论内容

#食管腺#

ASCO GI 2020：Zanidatamab在经过治疗的HER2+胃食管腺癌患者中显示出持久的抗肿瘤活性

2021-10-12

yuhaisheng_ibp_32061711 (审核中...)

前往app查看评论内容

#食管腺#

Br J Cancer：Mandard分级高：不代表食管腺癌对化疗无反应

2021-06-01

yuhaisheng_ibp_32061711 (审核中...)

前往app查看评论内容

#食管腺#

Lancet oncol：Margetuximab联合派姆单抗治疗HER2+的胃食管腺癌

2020-10-31

yuhaisheng_ibp_32061711 (审核中...)

前往app查看评论内容

#食管腺#

Clin Gastroenterology H: 性激素水平与食管腺癌和巴雷特食管风险之间的关系

2021-03-26

yuhaisheng_ibp_32061711 (审核中...)

前往app查看评论内容

#食管腺#

AJG：男性循环性激素水平和食管腺癌风险

2020-07-05

yuhaisheng_ibp_32061711 (审核中...)

前往app查看评论内容

#食管腺#

Journal of Clinical Oncology：Bemarituzumab治疗晚期胃食管腺癌的I期研究

2020-09-04

yuhaisheng_ibp_32061711 (审核中...)

前往app查看评论内容

#食管腺#

Clin Gastroenterology H：患有食管腺癌的年轻人晚期肿瘤发生风险更高并且存活时间更短

2019-10-27

yuhaisheng_ibp_32061711 (审核中...)

前往app查看评论内容

#食管腺#

CLIN CANCER RES：胃食管腺癌患者循环肿瘤DNA与临床结局之间的关系

2019-06-01

yuhaisheng_ibp_32061711 (审核中...)

前往app查看评论内容

#食管腺#

Gastroenterology：不同食管腺癌表型患者的预后差异

2019-03-23

yuhaisheng_ibp_32061711 (审核中...)

前往app查看评论内容

#食管腺#

JAMA Surg：胃和胃食管腺癌根治性切除术术中会诊假阴性率及影响因素

2018-12-28

yuhaisheng_ibp_32061711 (审核中...)

前往app查看评论内容

#食管腺#

Clinical Gastroenterology H：遗传变异与环境因素之间的相互作用影响食管腺癌和Barrett食管的风险

2018-11-07

yuhaisheng_ibp_32061711 (审核中...)

前往app查看评论内容

#食管腺#

DDS： Barrett食管的早期诊断能改善食管腺癌的生存率

2018-12-08

科室
- - 订阅+
  - 更多科室
工具
服务